基本情報
- CAS
83275-56-3- 標準SMILES
CCOC(=O)Nc1ccc2c(c1)N(C(=O)CN(C)C)c1ccccc1CC2- InChIKey
KJAMZCVTJDTESW-UHFFFAOYSA-N- 分子式
- C21H25N3O3
- 平均分子量
- 367.4 g/mol
- 単同位体質量
- 367.18959167
概要
Tiracizine is a dibenzooxazepine.
名称と識別子
- 優先名称
- Tiracizine
- IUPAC
- ethyl N-[11-[2-(dimethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate
- 現地名
- チラシジン
- 英語名
- Carbamic acid
- 分子式
- C21H25N3O3
- 分子量
- 367.44
名称と別名
Tiracizine83275-56-3TiracizinaTiracizinumDTXSID50487149UUO2T61K7DTXCID2028640Ethyl N-[5-[2-(dimethylamino)acetyl]-10,11-dihydro-5H-dibenz[b,f]azepin-3-yl]carbamateAWD-19-166Ethyl N-(5-(2-(dimethylamino)acetyl)-10,11-dihydro-5H-dibenz(b,f)azepin-3-yl)carbamateCarbamic acid, (5-((dimethylamino)acetyl)-10,11-dihydro-5H-dibenz(b,f)azepin-3-yl)-, ethyl ester, monohydrochlorideRefChem:898224
名称をさらに表示
エチル N-{2-[2-(ジメチルアミノ)アセチル]-2-アザトリシクロ[9.4.0.03,8]ペンタデカ-1(15),3,5,7,11,13-ヘキサエン-5-イル}カルバマートチラシジンTiracizinum [INN-Latin]ethyl N-[11-[2-(dimethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-9-yl]carbamateethyl N-[11-[2-(dimethylamino)ethanoyl]-5,6-dihydrobenzo[b][1]benzazepin-9-yl]carbamateN-[11-[2-(dimethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-9-yl]carbamic acid ethyl esterCarbamic acid, N-[5-[2-(dimethylamino)acetyl]-10,11-dihydro-5H-dibenz[b,f]azepin-3-yl]-, ethyl ester
C01EB11GS-1053-carbethoxyamino-5-dimethylaminoacetyl-2,2'-iminodibenzyl HClethyl N-(2-(2-(dimethylamino)acetyl)-2-azatricyclo(9.4.0.0^(3,8))pentadeca-1(15),3(8),4,6,11,13-hexaen-5-yl)carbamateTiracizine [INN]ethyl N-[11-[2-(dimethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateTiracizine (INN)NCGC00160473-01
物性
構造計算による物性
- XLogP
- 3.1
- 極性表面積
- 61.9 Ų
- 水素結合供与体数
- 1
- 水素結合受容体数
- 4
- 回転可能結合数
- 5
- 重原子数
- 27
- 形式電荷
- 0
- 複雑度
- 525
物理化学的性質
- 融点
- 127 · 127-128 °C(Solv: isopropanol (67-63-0))
- 沸点
- 525.3 · 525.3±50.0 °C(Predicted)
- 比重(密度)
- 1 · 1+-.0.06 g/cm3(Predicted)
- 酸解離定数(Pka)
- 13.42 · 13.42±0.20(Predicted)
化学と産業
薬理情報
ATC Code
C - Cardiovascular system
QC - Cardiovascular system
MeSH Pharmacological Classification
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).
サプライヤー2 社
陕西缔都新材料有限公司81124267 17392282731 · [email protected]
湖北玖天生物医药科技有限公司027-88013699 17354350817 · [email protected]
関連反応
0 件
現在のフィルター条件では反応記録がありません。
化合物ノート
読み込み中…